Search Results - "Becker, Pamela Sue"

NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020 by Becker, Pamela Sue, Griffiths, Elizabeth A, Alwan, Laura M, Bachiashvili, Kimo, Brown, Anna, Cool, Rita, Curtin, Peter, Dinner, Shira, Gojo, Ivana, Hicks, Ashley, Kallam, Avyakta, Kidwai, Wajih Zaheer, Kloth, Dwight D, Kraut, Eric H, Landsburg, Daniel, Lyman, Gary H, Miller, Ryan, Mukherjee, Sudipto, Patel, Shiven, Perez, Lia E, Poust, Adam, Rampal, Raajit, Rosovsky, Rachel, Roy, Vivek, Rugo, Hope S, Shayani, Sepideh, Vasu, Sumithira, Wadleigh, Martha, Westbrook, Kelly, Westervelt, Peter, Burns, Jennifer, Keller, Jennifer, Pluchino, Lenora A

“…Management of febrile neutropenia (FN) is an integral part of supportive care for patients undergoing cancer treatment. The NCCN Guidelines for Hematopoietic…”
Get more information

Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology by Crawford, Jeffrey, Becker, Pamela Sue, Armitage, James O, Blayney, Douglas W, Chavez, Julio, Curtin, Peter, Dinner, Shira, Fynan, Thomas, Gojo, Ivana, Griffiths, Elizabeth A, Hough, Shannon, Kloth, Dwight D, Kuter, David J, Lyman, Gary H, Mably, Mary, Mukherjee, Sudipto, Patel, Shiven, Perez, Lia E, Poust, Adam, Rampal, Raajit, Roy, Vivek, Rugo, Hope S, Saad, Ayman A, Schwartzberg, Lee S, Shayani, Sepideh, Talbott, Mahsa, Vadhan-Raj, Saroj, Vasu, Sumithira, Wadleigh, Martha, Westervelt, Peter, Burns, Jennifer L, Pluchino, Lenora

“…Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This…”
Get more information

Relation between measurable residual disease and morphologic relapse in AML by Shih, Lauren, Othus, Megan, Gardner, Kelda, Shaw, Carole, Halpern, Anna B., Becker, Pamela Sue, Walter, Roland B., Estey, Elihu, Percival, Mary-Elizabeth M.

“…Abstract only 7535 Background: Measurable residual disease (MRD) in AML portends a poor prognosis. The outcomes and treatments of MRD after an initial MRD…”
Get full text

Early discharge after induction chemotherapy for acute myeloid leukemia: Safety outcomes and hospital readmissions by Baclig, Nikita V., Buckley, Sarah A., Halpern, Anna B., Hendrie, Paul C., Percival, Mary-Elizabeth M., Becker, Pamela Sue, Estey, Elihu, Walter, Roland B.

“…Abstract only…”
Get full text

A phase III trial to evaluate the efficacy of uproleselan (GMI-1271) with chemotherapy in patients with relapsed/refractory acute myeloid leukemia by DeAngelo, Daniel J., Erba, Harry Paul, Jonas, Brian Andrew, O'Dwyer, Michael, Marlton, Paula, Huls, Gerwin A, Liesveld, Jane, Cooper, Brenda W., Bhatnagar, Bhavana, Armstrong, Michael, Fogler, William, Chen, Mary, Magnani, John, Thackray, Helen M., Advani, Anjali S., Becker, Pamela Sue

“…Abstract only TPS7066 Background: Binding of E-selectin (E-sel) to sialyl Le x , the E-sel ligand (E-sel-L), on the leukemic cell surface activates cell…”
Get full text

Cancer- and chemotherapy-induced anemia by Rodgers, 3rd, George M, Becker, Pamela Sue, Blinder, Morey, Cella, David, Chanan-Khan, Asher, Cleeland, Charles, Coccia, Peter F, Djulbegovic, Benjamin, Gilreath, Jeffrey A, Kraut, Eric H, Matulonis, Ursula A, Millenson, Michael M, Reinke, Denise, Rosenthal, Joseph, Schwartz, Rowena N, Soff, Gerald, Stein, Richard S, Vlahovic, Gordana, Weir, 3rd, Alva B

“…Anemia is prevalent in 30% to 90% of patients with cancer. Anemia can be corrected through either treating the underlying cause or providing supportive care…”
Get more information

Prognostic implication of minimal residual disease in AML by Al-Khinji, Aisha, Shaw, Carole, Walter, Roland B., Becker, Pamela Sue, Hendrie, Paul, Shannon Dorcy, Kathleen Kay, Estey, Elihu H

“…Abstract only…”
Get full text

Durable response with venetoclax in combination with decitabine or azacitadine in elderly patients with acute myeloid leukemia (AML) by Dinardo, Courtney Denton, Pratz, Keith William, Potluri, Jalaja, Pullarkat, Vinod A., Jonas, Brian Andrew, Wei, Andrew H., Becker, Pamela Sue, Frankfurt, Olga, Xu, Tu, Hong, Wan-Jen, Chyla, Brenda, Pollyea, Daniel Aaron, Letai, Anthony G.

“…Abstract only…”
Get full text

Myeloid growth factors by Crawford, Jeffrey, Armitage, James, Balducci, Lodovico, Becker, Pamela Sue, Blayney, Douglas W, Cataland, Spero R, Heaney, Mark L, Hudock, Susan, Kloth, Dwight D, Kuter, David J, Lyman, Gary H, McMahon, Brandon, Rugo, Hope S, Saad, Ayman A, Schwartzberg, Lee S, Shayani, Sepideh, Steensma, David P, Talbott, Mahsa, Vadhan-Raj, Saroj, Westervelt, Peter, Westmoreland, Michael, Dwyer, Mary, Ho, Maria

“…Febrile neutropenia, a common side effect of myelosuppressive chemotherapy in patients with cancer, can result in prolonged hospitalization and broad-spectrum…”
Get more information

Cancer- and chemotherapy-induced anemia by Rodgers, 3rd, George M, Becker, Pamela Sue, Bennett, Charles L, Cella, David, Chanan-Khan, Asher, Chesney, Carolyn, Cleeland, Charles, Coccia, Peter F, Djulbegovic, Benjamin, Garst, Jennifer L, Gilreath, Jeffrey A, Kraut, Eric H, Lin, Weei-Chin, Matulonis, Ursula, Millenson, Michael, Reinke, Denise, Rosenthal, Joseph, Sabbatini, Paul, Schwartz, Rowena N, Stein, Richard S, Vij, Ravi

Get more information